...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: from IR/Chris
3
Dec 15, 2022 12:23PM

Thanks.  And Thanks to Koo-Koo2.  I just don't recall seeing that 6% before.

 

 

2
Dec 15, 2022 02:03PM
1
Dec 15, 2022 02:25PM
1
Dec 15, 2022 03:10PM
Share
New Message
Please login to post a reply